Opmed.AI

Operating Room Scheduling and Management

Health Tech & Life Sciences
Private
Follow

Company Overview

Snapshot

Founded in January 2020 by Mor Brokman, Dr. Mor, Amos Haggiag, Prof. Baruch, and Avi Paz, Opmed.AI operates with 11–50 employees. The company has successfully raised $15.98 million across 4 funding rounds from 6 investors. In May 2024, Opmed.AI secured Series A funding, with NFX Capital and Grove Ventures participating.

Business overview

Opmed.AI develops an AI-powered optimization platform for healthcare operations, specifically focusing on operating room scheduling and management. The company's core technology utilizes AI and network science to analyze the complex interdependencies within an operating room, moving beyond conventional scheduling methods that treat procedures as isolated blocks. By viewing the OR as a dynamic network, Opmed.AI enables healthcare providers to make strategic decisions, optimize resource allocation, predict disruptions, and adapt to changing circumstances. The platform serves hospitals and healthcare centers in markets such as the U.S. and Israel, operating within the Health Tech & Life Sciences sector, with a focus on Digital Healthcare and Clinical Workflow solutions.

Strategic signal

In May 2024, Opmed.AI raised $15 million in Series A funding, with participation from NFX Capital. This significant capital injection validates the company's technology and its potential to address critical inefficiencies in operating room management. The funding will enable Opmed.AI to expand its presence across the U.S. and meet growing demand from hospitals, signaling strong market traction and investor confidence in its AI-driven solution for improving resource allocation and operational efficiency in healthcare.

Log in to access full profile

Company Intelligence Q&A

What was Opmed.AI's most recent funding round?
In May 2024, Opmed.AI secured Series A funding, with NFX Capital and Grove Ventures participating.
Which investors participated in Opmed.AI's May 2024 funding round?
The May 2024 Series A funding round for Opmed.AI saw participation from NFX Capital.
When was Opmed.AI founded and by whom?
Opmed.AI was founded in January 2020 by Mor Brokman, Dr. Mor, Amos Haggiag, Prof. Baruch, and Avi Paz.
What is the primary focus of Opmed.AI's technology?
Opmed.AI's technology focuses on optimizing operating room scheduling and management by using AI and network science to analyze and manage the complex interdependencies within an OR.
Has Opmed.AI received any non-equity funding recently?
In January 2024, Opmed.AI received a grant from the BIRD Foundation, a joint U.S.-Israeli initiative that provides funding for cooperative industrial R&D projects.
Log in to access full profile